🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?Explore for Free

AMC Entertainment, Tesla and Exxon Rise Premarket

Published 02/01/2021, 08:06 AM
Updated 02/01/2021, 08:08 AM
© Reuters.
CVX
-
BB
-
XOM
-
PIPR
-
MS
-
WPM
-
GME
-
TSLA
-
HZNP
-
CDE
-
HL
-
AMC
-
BAYRY
-
SPCE
-
VIE
-
OTIS
-
CVAC
-

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Monday, February 1st. Please refresh for updates.

  • GameStop (NYSE:GME) stock fell 0.4%, AMC Entertainment (NYSE:AMC) stock rose 20% and BlackBerry (NYSE:BB) rose 3.1%, as volatility in a handful of heavily-shorted stocks continued against a backdrop of continued restrictions on trading by Robinhood and others. 

  • Exxon Mobil (NYSE:XOM) stock rose 1.3% and Chevron (NYSE:CVX) stock climbed 1.4% after the Wall Street Journal reported that the oil giants discussed a merger last year as the oil price slumped into negative territory. The paper described the talks as preliminary, but such a deal, if it were to occur, would be one of the largest in corporate history.

  • Viela Bio (NASDAQ:VIE) stock soared 53% after Horizon Therapeutics (NASDAQ:HZNP), down 0.7%, announced a deal to buy its rival in a deal valued at just over $3 billion in order to gain experimental treatments for rare diseases.

  • Virgin Galactic (NYSE:SPCE) stock rose 9.3% after the company announced on Monday that it will redo its aborted December flight test as early as Feb. 13, even after Morgan Stanley (NYSE:MS) downgraded its investment stance to ‘equal weight’ from ‘overweight’ after the stock’s recent sharp gains. 

  • Hecla Mining (NYSE:HL) stock rose 22%, Coeur Mining (NYSE:CDE) climbed 32% and Wheaton Precious Metals (NYSE:WPM) rose 14% as the silver miners benefitted from the retail surge into the metal. 

  • Tesla (NASDAQ:TSLA) stock rose 3.1% after Piper Sandler (NYSE:PIPR) raised its price target to a Street high of $1,200 per share from $515 a share, citing new opportunities that will pay out over decades.

  • CureVac (NASDAQ:CVAC) stock rose 12% with the German drugmaker set to get help from Bayer (OTC:BAYRY) for its experimental Covid-19 vaccine in order to boost its manufacturing capacity.

  • Otis Worldwide (NYSE:OTIS) stock rose 2.9% after the world’s biggest producer of escalators and elevators reported earnings and revenue ahead of estimates as well as positive guidance for 2021. 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.